Form 4: United Therapeutics Director Tommy G Thompson Executes Share Tracking Award and Sells Shares
SEC Form 4
Director Tommy G Thompson exercised share tracking awards and sold shares of United Therapeutics Corp on March 11, 2024.
Summary
- On March 11, 2024, Tommy G Thompson, a director of United Therapeutics Corporation, executed a transaction involving share tracking awards and common stock.
- Thompson exercised share tracking awards for 5,000 shares at a price of $88.03.
- Concurrently, Thompson disposed of 5,000 shares of common stock at a price of $249.51.
- Following these transactions, Thompson directly owns 8,480 shares of United Therapeutics Corporation.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a routine transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of insider trading activity and are used by investors to gauge sentiment of company directors and officers.
Stakeholder Impact
- The transaction may influence investor perception of United Therapeutics, potentially affecting the stock price.
Key Dates
| Date | Description |
|---|---|
| 06/26/2015 | Date Share Tracking Award became exercisable |
| 03/11/2024 | Date of transaction: execution of share tracking award and sale of shares |
| 03/12/2024 | Date of signature on the Form 4 filing |
| 06/26/2024 | Expiration date of Share Tracking Award |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.